New prostate cancer targets for diagnosis, imaging, and therapy: focus on prostate-specific membrane antigen

A Cimadamore, M Cheng, M Santoni… - Frontiers in …, 2018 - frontiersin.org
The rising incidence rate of the cancer in the prostate gland has increased the demand for
improved diagnostic, imaging, and therapeutic approaches. Prostate-specific membrane …

Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT

M Eiber, K Herrmann, J Calais… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented
accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly …

Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission …

VH Meissner, I Rauscher, K Schwamborn, J Neumann… - European Urology, 2022 - Elsevier
A biopsy-free diagnostic pathway in prostate cancer (PC) is limited by the diagnostic
accuracy of multiparametric magnetic resonance imaging (mpMRI). The improved accuracy …

Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer

RM Hicks, JP Simko, AC Westphalen, HG Nguyen… - Radiology, 2018 - pubs.rsna.org
Purpose To compare the diagnostic accuracy of gallium 68 (68Ga)–labeled prostate-specific
membrane antigen (PSMA)–11 PET/MRI with that of multiparametric MRI in the detection of …

Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting

AK Miyahira, KJ Pienta, JW Babich, NH Bander… - The …, 2020 - Wiley Online Library
Abstract Introduction The Prostate Cancer Foundation (PCF) convened a PCF prostate‐
specific membrane antigen (PSMA) Theranostics State of the Science Meeting on 18 …

Diagnostic accuracy of 68Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade intra …

MJ Scheltema, JI Chang, PD Stricker… - BJU …, 2019 - Wiley Online Library
Objective To evaluate the ability of prostate‐specific membrane antigen (PSMA)‐positron‐
emission tomography (PET)/computed tomography (CT) to detect intermediate‐grade intra …

Patients resistant against PSMA-targeting α-radiation therapy often harbor mutations in DNA damage-repair–associated genes

C Kratochwil, FL Giesel, CP Heussel… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA)–targeting α-radiation therapy (TAT) is an
emerging treatment modality for metastatic castration-resistant prostate cancer. There is a …

68Ga-PSMA positron emission tomography/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative …

E Lopci, A Saita, M Lazzeri, G Lughezzani… - The Journal of …, 2018 - Elsevier
Purpose 68 Ga labeled prostate specific membrane antigen positron emission tomography/
computerized tomography may represent the most promising imaging modality to identify …

Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology

BM Privé, B Israël, MGM Schilham… - Prostate cancer and …, 2021 - nature.com
Background PSMA-PET is a novel imaging modality for the staging of prostate cancer (PCa).
While there are several PSMA ligands available, F-18-PSMA-1007 is particularly of interest …

Detection and localisation of primary prostate cancer using 68gallium prostate‐specific membrane antigen positron emission tomography/computed tomography …

AA Kalapara, T Nzenza, HYC Pan, Z Ballok… - BJU …, 2020 - Wiley Online Library
Objective To compare the accuracy of 68gallium prostate‐specific membrane antigen
positron emission tomography/computed tomography (68Ga‐PSMA PET/CT) with …